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Infl uenza A(H1N1) Infektion und schwere kardiale 
Dysfunktion bei Erwachsenen: Eine Fallserie
Zusammenfassung. Hintergrund: Während die virale My-
okarditis und das Herzversagen anerkannte und gefürch-
tete Komplikationen einer saisonalen Infl uenza A Infektion 
sind, liegen bislang nur wenig Informationen über ein 
durch das 2009 Infl uenza A(H1N1) Virus induziertes Herz-
versagen vor.
Methoden und Hauptergebnisse: Diese Fallsammlung 
fasst den Krankheitsverlauf von vier Patienten mit 2009 In-
fl uenza A(H1N1) Infektion zusammen, welche an unserer 
Klinik im Zeitraum von November 2009 bis September 
2010 behandelt wurden. Alle Patienten präsentierten sich 
mit einer schweren kardialen Funktionsstörung (akutes 
Herzversagen, kardiogener Schock oder Herzkreislaufstill-
stand im Rahmen eines Kammerfl immerns) als das füh-
rende Symptom einer Infl uenza A(H1N1) Infektion. Zwei 
Patienten waren mit hoher Wahrscheinlichkeit kardial 
vorerkrankt, und drei benötigten eine Katecholaminthera-
pie, um die hämodynamische Funktion zu stabilisieren. 
Mit Ausnahme eines Patienten der vor der Diagnosestel-
lung der Infl uenza A(H1N1) Infektion verstarb, wurden 
alle Patienten mit einer antiviralen Th erapie mit Oseltami-
vir und supportiver Intensivtherapie behandelt. Ein Acute 
Respiratory Distress Syndrom infolge der Infl uenza 
A(H1N1) Infektion trat bei einem Patienten auf. Die Herz-
funktion normalisierte sich bei zwei Patienten und war 
bei einem Patienten noch bei Krankenhausentlassung 
 eingeschränkt.
Schlussfolgerung: Eine Infl uenza A(H1N1) Infektion 
kann mit einer schweren kardialen Funktionseinschrän-
kung assoziiert sein. Diese kann sich sogar als führendes 
klinisches Symptom darstellen. Während einer Infl uenza 
Pandemie kann eine genaue Anamneseerhebung Grippe-
ähnliche Symptome hervorbringen und sollte auch bei 
kritisch kranken Patienten mit akutem Herzversagen eine 
Diagnostik auf H1N1 Infektion veranlassen.
Summary. Background: While viral myocarditis and heart 
failure are recognized and feared complications of  seasonal 
infl uenza A infection, only limited information is available 
for 2009 infl uenza A(H1N1)-induced heart failure. 
Methods and main fi ndings: Th is case series summa-
rizes the disease course of four patients with 2009 infl u-
enza A(H1N1) infection who were treated at our institution 
from November 2009 until September 2010. All patients 
presented with severe cardiac dysfunction (acute heart 
failure, cardiogenic shock or cardiac arrest due to ven-
tricular fi brillation) as the leading symptom of infl uenza 
A(H1N1) infection. Two patients most likely had pre-exist-
ent cardiac pathologies, and three required catecholamine 
therapy to maintain hemodynamic function. Except for 
one patient who died before infl uenza A(H1N1) infection 
had been diagnosed, all patients received antiviral therapy 
with oseltamivir and supportive critical care. Acute respi-
ratory distress syndrome due to infl uenza A(H1N1) infec-
tion developed in one patient. Heart function normalized 
in two of the three surviving patients but remained im-
paired in the other one at hospital discharge.
Conclusions: Infl uenza A(H1N1) infection may be asso-
ciated with severe cardiac dysfunction which can even be 
the leading clinical symptom at presentation. During an 
infl uenza pandemic, a thorough history may reveal fl u-like 
symptoms and should indicate testing for H1N1 infection 
also in critically ill patients with acute heart failure.
Key words: Infl uenza, H1N1, acute heart failure, cardiac 
arrest, cardiogenic shock.
Introduction
During 2009, a novel infl uenza A virus of swine origin 
(H1N1) emerged to cause human infection [1–3]. Th e virus 
rapidly spread worldwide and caused a serious infl uenza 
pandemic throughout the Southern hemisphere in 2009 
[4]. In fall of 2009, its activity increased again in the North-
ern hemisphere [5]. As of August 1, 2010, at least 18,449 
deaths due to laboratory confi rmed infections with the 
H1N1 virus were reported to the World Health Organiza-
tion from 214 countries [5].
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Although viral myocarditis and heart failure are well-
recognized and feared complications of seasonal infl u-
enza A infection [6], only limited information on 
H1N1-induced heart failure has been reported so far 
[7–10]. Th is case series summarizes the disease course of 
four patients with 2009 infl uenza A(H1N1) infection who 
were treated at our institution from November 2009 until 
September 2010. All patients presented with acute heart 
failure, cardiogenic shock or cardiac arrest as the leading 
symptom. Th e institutional review board of the Inselspital 




A 55-year-old Caucasian female was admitted because of 
ventricular tachycardia after complaining about fl u-like 
symptoms and palpitations. She had experienced a self-
limited episode of palpitations one month earlier. Echocar-
diography revealed a dilated left ventricle with anterior wall 
akinesia and reduced ejection fraction (10–15%). Since 
ventricular tachycardia persisted despite pharmacologic 
and electric cardioversion attempts, the patient was trans-
ferred to this hospital. Coronary angiography showed that 
chronic occlusion of the left anterior descending coronary 
artery considered inappropriate for revascularization. An 
intra-aortic balloon pump was inserted, and the patient 
was intubated. On admission to the intensive care unit 
(ICU), she presented with cardiogenic shock (arterial blood 





 quotient, 145; pulmonary arte-
rial occlusion pressure, 24 mmHg), and persistent 
ventricular tachycardia. Th ree episodes of ventricular fi bril-
lation were terminated by defi brillation. After repeated ad-
ministration of amiodarone and lidocaine, and institution 
of a glucose-insulin-potassium infusion, ventricular tachy-
cardia was electrically converted into sinus rhythm. Th e pa-
tient required catecholamines (dobutamine, epinephrine) 
and milrinone. Laboratory investigations for possible high 
urgency heart transplantation were ordered, and implanta-
tion of a left ventricular assist device was discussed. Addi-
tionally, a nasopharyngeal swab for infl uenza H1N1 was 
obtained [11]. By ICU day 2, hemodynamic function slightly 
improved and nitroprusside was started. After receipt of the 
positive H1N1 virus test results, she was started on osel-
tamivir (2 × 150 mg/d). During the following days, cardio-
genic shock resolved, and the patient was weaned off  the 
mechanical ventilator. Six days after admission, she was 
transferred to the cardiology ward. Oseltamivir treatment 
was continued for ten days. At hospital discharge, left ven-
tricular ejection fraction remained low at 15–20%.
Case 2
A 59-year-old Caucasian male presented to a district hos-
pital with dyspnea and fl u-like symptoms. Echocardiogra-
phy showed dilatation of the right ventricle, 
interventricular septal bulging, and decreased left ven-
tricular ejection fraction (15–20%). After an epinephrine 
infusion had been started because of arterial hypotension 
(62/45/35 mmHg), the patient was transferred to this ICU. 
On admission, he remained hypotensive (mean arterial 
pressure, 35–45 mmHg) with lactic acidosis (arterial lac-
tate, 22 mmol/L; arterial pH, 6.8) and required repetitive 
epinephrine bolus injections, dobutamine, endotracheal 





 quotient 400). As the right 
ventricle remained dilated in echocardiography and car-





on the electrocardiogram, pulmonary embolism was sus-
pected. Intravenous thrombolysis with 100 mg alteplase 
(Actilyse®; Boehringer Ingelheim, Basel, Switzerland) was 
performed. Nevertheless, hemodynamic function contin-
ued to deteriorate, and epinephrine requirements in-
creased. Six hours following admission, the patient died 
from refractory cardiogenic shock. Th e post-mortem ex-
amination found a dilated and hypertrophic heart (610 g) 
with amyloidosis and moderate coronary sclerosis but no 
fresh thrombus. Signs of chronic pulmonary arterial hy-
pertension, pulmonary edema, and tracheitis but no pul-
monary embolus was detected. A nasopharyngeal swab 
collected on ICU admission turned out positive for H1N1.
Case 3
After fi ve days of fl u-like symptoms, a 43-year-old female 
returned to work where ventricular fi brillation occurred. 
Following four cycles of cardiopulmonary resuscitation by 
the ambulance service, return of spontaneous circulation 
was achieved. On hospital admission, blood pressure was 
stable (100/70/52 mmHg) and echocardiography revealed 
preserved biventricular pump function without regional 
wall motion abnormalities or pericardial eff usion. No in-
tracranial pathology or pulmonary embolism was detected 
on computed tomography. Shortly after ICU admission, the 
patient experienced another three episodes of ventricular 
fi brillation requiring defi brillation. Th erapeutic hypother-
mia (33–34°C) was initiated for 12 hours. Following re-
warming, a coronary angiography showed no signs of 
coronary artery disease. Th e nasopharyngeal swab taken at 
ICU admission was positive for H1N1. Oseltamivir 





 quotient, 450) but mild bi-
lateral infi ltrates were seen on chest X-ray. After withdrawal 
of sedation, the patient developed focal seizures. An elec-
troencephalogram showed status epilepticus which was 
treated with levetiracetam (2 × 1 g/d), propofol, and eventu-
ally additional clonazepam and valproic acid. While cardio-
vascular function remained stable and no further 
arrhythmias occurred, she remained unconscious  (Glasgow 
Coma Scale 6) despite cessation of epileptic activity. After 
tracheostomy and weaning from the mechanical ventilator, 
the patient was discharged to a neurologic rehabilitation 
unit with persistent neurologic impairment on ICU day 14.
Case 4
Following an eight days history of upper respiratory tract 
infection with fi ve days of antibiotic treatment (erythromy-
cin and amoxicillin), a 29-year-old Indian female was trans-
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ferred to our ICU from a regional hospital center with acute 
respiratory and heart failure. Initial echocardiography re-
vealed impaired left ventricular function (left  ventricular 
ejection fraction 40%) without regional abnormalities. At 
ICU admission, she presented with acute left heart failure 
(cardiac output, 2.4 L/min/m2; pulmonary capillary occlu-
sion pressure, 21 mmHg; mixed venous oxygen saturation, 





150). Her laboratory studies were notable for elevated 
plasma troponin T (0.052 µg/L) and creatinkinase levels 
(757 IU/L) (Table 1). Th e patient was started on dobutamine 
and subsequently nitroprusside infusion. A computerto-
mography scan of the chest displayed dense bilateral peri-
hilar infi ltrates. Empiric antibiotic therapy with ceftriaxone, 
levofl oxacin, and vancomycin was installed. A nasal swab 
taken on ICU admission proved positive for infl uenza 
A(H1N1). Treatment with oseltamivir (2 × 150 mg/d) was 
initiated. Her subsequent course was procrastinated as she 
developed severe acute respiratory distress secondary to 
infl uenza A(H1N1) infection. Hemodynamic support was 
required until ICU day 8 after which cardiac function had 
normalized. Th e patient could only be weaned off  the ven-
tilator slowly and underwent tracheotomy on ICU day 14. 
Twenty-eight days after ICU admission, the patient was dis-
charged to a pulmonary ward with normalized heart func-
tion but impaired respiratory  capacity.
Discussion
In all presented patients with proven infl uenza A(H1N1) 
infection, acute heart failure, cardiogenic shock or cardiac 
arrest was the cause for hospital or ICU admission. It is im-
possible to diff erentiate from the data of this case series 
whether acute heart failure represented H1N1-induced 
myocarditis or secondary myocardial dysfunction [12]. 
Th us, also pre-existing cardiac disease may predispose to 
infl uenza A(H1N1) infection. Although the clinical course 
of patients 3 and 4 closely resembled viral myocarditis, this 
clinical suspicion could not be ascertained as myocardial 
biopsy was refrained from due to lacking therapeutic con-
sequences. Similarly, it remains unclear to which extent 
H1N1 infection contributed to acute deterioration of pump 
function in patients 1 and 2. 
Given that all patients had a history of fl u-like symp-
toms, it is unlikely that they were asymptomatic H1N1 car-
riers independently experiencing acute heart failure. 
Nonetheless, their initial presentation of acute heart fail-
ure was severe in all patients overriding characteristic 
signs of infl uenza A(H1N1). Only thorough examination of 
the patient’s history allowed establishment of the diagno-
sis of H1N1 infection. Although it is unclear to what extent 
antiviral therapy contributed to the improvement of heart 
function in patients 1, 3 and 4, it is possible that treatment 
of H1N1 infection was benefi cial for the recovery of heart 
function.
So far, emerging but limited data on H1N1-associated 
cardiac dysfunction is available. Th e major case series of 
2009 infl uenza A(H1N1) infections [1, 4, 7, 9 13–17] did not 
report any patient with acute heart failure as the leading 
clinical symptom. Just recently, Martin et al. have retro-
spectively identifi ed reversible cardiac dysfunction in six 
out of 123 cases (4.9%) with infl uenza A(H1N1) infection 
Table 1. Patient characteristics and clinical symptoms
Case 1 Case 2 Case 3 Case 4
Age (years) 55 59 43 29
Gender female male female female
Ethnic group Caucasian Caucasian Caucasian Indian
Premorbidities bronchial asthma,
tobacco abuse (25 py)
multiple myeloma, retinitis 
pigmentosa, arterial hypertension, 
atrial fibrillation
hypothyroidism epilepsy,
diabetes mellitus type I
Days of Flu-like symptoms 2 3 5 8
Flu-like symptoms fever, headache, myalgia, 
dyspnea
fever, cough, fatigue, headache fever, chills, cough fever, cough, fatigue, myalgia
First white blood cell count (G/L) 12.2 5.6 8.6 7.7
First C-reactive protein (mg/L) 126 32 <3 35
max. Creatinkinase (IU/L) 977 1286 931 757
max. Creatinkinase MB (IU/L) 6.3 138.9 31 3.8
max.Troponin T (mg/L) 0.139 3.06 0.24 0.052
Initial presentation at admission ventricular tachycardia, 
cardiogenic shock
biventricular heart failure cardiac arrest acute left heart failure
SAPS II (pts) 52 62 58 32
max. SOFA Score (pts) 9 11 8 181
Length of ICU stay (days) 6 1 14 28
ICU mortality alive dead alive alive
py pack years; SAPS Simplified Acute Physiology Score; SOFA Sequential Organ Failure Assessment; ICU intensive care unit.
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[10]. However, none of these cases initially presented with 
symptoms of acute heart failure. One patient with fulmi-
nant myocarditis was excluded from the ANZECMO study 
but was not reported in more detail [18]. Two patients in 
the English cohort [9] had cardiac causes of death possibly 
related to infl uenza A(H1N1) infection. A case of biopsy 
proven myocarditis which was associated with acute H1N1 
infection was published in the Finnish literature [8]. Ful-
minant myocarditis has been reported in children infected 
with the pandemic infl uenza A(H1N1) virus [19]. In our 
own experience, all other cases of 2009 infl uenza A(H1N1) 
who had so far been admitted to our ICU, presented with 
fl u-like symptoms and signs of respiratory tract infection 
(8 cases) except for one case of acute brain trauma where 
test results coincidentally revealed asymptomatic carrier 
status.
Considering that the H1N1 virus strain is a subtype of 
the infl uenza type A viral group [2], which was repeatedly 
associated with cardiotoxicity [6], the lack of reports of 
heart failure in patients with 2009 infl uenza A(H1N1) is 
surprising. Th is fi nding may refl ect a certain publication 
bias. On the other hand, it could be speculated that infl u-
enza A(H1N1) testing has so far been performed only spo-
radically in patients admitted because of cardiogenic 
shock or cardiac arrest. In contrast to acute heart failure as 
the leading symptom of H1N1 infection, fi rm evidence ex-
ists that patients with chronic cardiovascular diseases are 
at increased risk of acquiring H1N1 infection and thus car-
diovascular disease could be considered as a pre-existing 
condition [13–17, 20]. Accordingly, it must be assumed 
that patients 1 and 2 had a chronic cardiac pathology. Al-
though not diagnosed beforehand, the post-mortem ex-
amination revealed cardiac amyloidosis and hypertrophy 
with pulmonary arterial hypertension in patient 2 suggest-
ing that his cardiomyopathy was pre-existent. Similarly, 
the history of palpitations earlier before admission in pa-
tient 1 together with chronic occlusion of the left anterior 
descending coronary artery indicate that she suff ered from 
chronic coronary artery disease.
Although this case series presents the individual dis-
ease course of four patients only and can establish neither 
the actual incidence of heart failure in 2009 infl uenza 
A(H1N1) infection nor a causative relationship between 
H1N1 infection and heart failure, we believe that relevant 
clinical conclusions can be drawn form this report: First, in 
critically ill patients presenting with acute heart failure or 
other critical illness a thorough history may reveal fl u-like 
symptoms and should indicate testing for H1N1 infection. 
Second, infection with the 2009 infl uenza A(H1N1) virus 
may be associated with acute heart failure and cardiac ar-
rest as the leading clinical symptom.
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